Clinical Evaluation of an AKG-PQQ-Agaricus bisporus Composition for Mitochondrial Function and Healthy Aging
Frontiers in Science and Engineering · 22.04.2026 · 6 (4) · 167-173
DOI: 10.54691/twy7kk04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Science and Engineering, online erschienen am 22.04.2026. Verfasst von Nour-Eddine Ziraoui und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
A formulation centered on alpha-ketoglutarate (AKG), pyrroloquinoline quinone disodium salt (PQQ), and Agaricus bisporus extract is intended to support mitochondrial resilience through complementary energetic, redox, and cytoprotective mechanisms.
Objective
We evaluated the translational and clinical relevance of this combination by integrating our formulation-level comparison data with published human clinical evidence for AKG-related interventions, PQQ, and ergothioneine-rich mushroom or ergothioneine supplementation.
Methods
We retained the original composition framework and in vitro comparison of the study formulation and matched them with publicly available human intervention studies identified from primary biomedical literature.
Results
In our formulation comparison, the index composition was associated with higher relative mitochondrial membrane potential and lower mitochondrial reactive oxygen species than the comparator that omitted Agaricus bisporus extract. Across human studies, PQQ showed the most mature evidence base, with randomized trials reporting improvements in inflammatory markers, selected cognitive domains, muscle strength, and some indices related to mitochondrial biogenesis. Ergothioneine-containing mushroom and purified ergothioneine trials demonstrated human bioavailability, safety, and signals in cognition, sleep-related outcomes, and skin hydration. Direct completed efficacy trials for AKG in healthy-aging settings remain limited, although active randomized trial programs indicate strong translational interest.
Conclusions
The combined evidence supports a credible mitochondria-focused rationale for the AKG-PQQ-Agaricus bisporus composition, but a registered head-to-head randomized trial of the full formulation is still needed before superiority claims can be made.
Zitieren
APA
Ziraoui, N., González, M., & Romano, S. (2026). Clinical Evaluation of an AKG-PQQ-Agaricus bisporus Composition for Mitochondrial Function and Healthy Aging. Frontiers in Science and Engineering, 6(4), 167-173. https://doi.org/10.54691/twy7kk04
Vancouver
Ziraoui N, González M, Romano S. Clinical Evaluation of an AKG-PQQ-Agaricus bisporus Composition for Mitochondrial Function and Healthy Aging. Frontiers in Science and Engineering. 2026;6(4):167-173. doi:10.54691/twy7kk04
BibTeX
@article{Ziraoui2026,
author = {Ziraoui, Nour-Eddine and González, Mateo and Romano, Salvatore},
title = {Clinical Evaluation of an AKG-PQQ-Agaricus bisporus Composition for Mitochondrial Function and Healthy Aging},
journal = {Frontiers in Science and Engineering},
year = {2026},
volume = {6},
number = {4},
pages = {167--173},
doi = {10.54691/twy7kk04}
}
EUVIMED